Furthermore, the expression patterns of ATP7A and ATP7B significantly affect the prognosis of glioma: high expression of ATP7A is associated with poor clinical prognosis, while low expression of ATP7B is also associated with poor prognosis. Here, ATP7A is linked to central nervous system cancer.